BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3311715)

  • 1. Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations of obese Zucker rats.
    Stein LJ; Dorsa DM; Baskin DG; Figlewicz DP; Porte D; Woods SC
    Endocrinology; 1987 Nov; 121(5):1611-5. PubMed ID: 3311715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats.
    Stein LJ; Dorsa DM; Baskin DG; Figlewicz DP; Ikeda H; Frankmann SP; Greenwood MR; Porte D; Woods SC
    Endocrinology; 1983 Dec; 113(6):2299-301. PubMed ID: 6357768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat.
    Israel PA; Park CR; Schwartz MW; Green PK; Sipols AJ; Woods SC; Porte D; Figlewicz DP
    Brain Res Bull; 1993; 30(5-6):571-5. PubMed ID: 8457906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats.
    Alemzadeh R; Holshouser S
    Endocrinology; 1999 Jul; 140(7):3197-202. PubMed ID: 10385415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man.
    Wallum BJ; Taborsky GJ; Porte D; Figlewicz DP; Jacobson L; Beard JC; Ward WK; Dorsa D
    J Clin Endocrinol Metab; 1987 Jan; 64(1):190-4. PubMed ID: 3536982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E; Velasco B; Barrios R; Sanchez-Franco F
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinism in patients with coronary artery disease.
    Job FP; Wolfertz J; Meyer R; Hübinger A; Gries FA; Kuhn H
    Coron Artery Dis; 1994 Jun; 5(6):487-92. PubMed ID: 7952407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pancreatic and plasma insulin in prenatal and suckling Zucker rats.
    Turkenkopf IJ; Johnson PR; Greenwood MR
    Am J Physiol; 1982 Apr; 242(4):E220-5. PubMed ID: 7039359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia and smooth muscle cell proliferation.
    Ridray S
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S39-51. PubMed ID: 7550537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivity to somatostatin in obese Zucker rats.
    Bender H; Schusdziarra V; Pfeiffer EF
    Clin Physiol Biochem; 1985; 3(1):1-7. PubMed ID: 2859937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis.
    Gerozissis K; Orosco M; Rouch C; Nicolaidis S
    Brain Res; 1993 May; 611(2):258-63. PubMed ID: 8334519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of glycated hemoglobin to assess Glycemic control in Wistar diabetic fatty rats and Zucker fatty rats.
    Albright AL; Johnson PR; Greene S; Stern JS
    Obes Res; 1994 Nov; 2(6):535-9. PubMed ID: 16358402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue hyperplasia and hyperinsulinemia on Zucker obese female rats: a developmental study.
    Johnson PR; Stern JS; Greenwood MR; Hirsch J
    Metabolism; 1978 Dec; 27(12 Suppl 2):1941-54. PubMed ID: 723643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats.
    Freedman MR; Stern JS; Reaven GM; Mondon CE
    Horm Metab Res; 1986 May; 18(5):296-8. PubMed ID: 3522389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipoblasts from the Zucker fafa rat.
    Goldstein AL; Greenwood MR; Johnson PR; Palmer JE; Turkenkopf IJ; Francendese A
    Int J Obes; 1985; 9 Suppl 1():55-60. PubMed ID: 3840774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of insulin resistance by diazoxide in obese Zucker rats.
    Alemzadeh R; Slonim AE; Zdanowicz MM; Maturo J
    Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma insulin-like growth factor-I (IGF-I) and IGF-binding proteins.
    Nguyen-Yamamoto L; Deal CL; Finkelstein JA; Van Vliet G
    Endocrinology; 1994 Mar; 134(3):1382-8. PubMed ID: 7509740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
    Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
    Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.